Compare COGT & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | MHK |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.3B |
| IPO Year | 2018 | 1992 |
| Metric | COGT | MHK |
|---|---|---|
| Price | $39.70 | $125.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $32.08 | ★ $135.92 |
| AVG Volume (30 Days) | ★ 2.2M | 771.5K |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.71 |
| Revenue | N/A | ★ $10,722,900,000.00 |
| Revenue This Year | N/A | $0.33 |
| Revenue Next Year | N/A | $2.14 |
| P/E Ratio | ★ N/A | $18.42 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.72 | $96.24 |
| 52 Week High | $43.73 | $143.13 |
| Indicator | COGT | MHK |
|---|---|---|
| Relative Strength Index (RSI) | 61.99 | 66.96 |
| Support Level | $37.70 | $119.05 |
| Resistance Level | $40.40 | $125.39 |
| Average True Range (ATR) | 1.90 | 3.93 |
| MACD | 0.31 | 1.17 |
| Stochastic Oscillator | 83.19 | 93.94 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.